\documentclass[aspectratio=169]{beamer}
%\documentclass[handout]{beamer}

% language settings
%\usepackage{fontspec, polyglossia}
%\setdefaultlanguage{magyar}

% common packages
\usepackage{amsmath, multimedia, hyperref, color, multirow}
%\usepackage{graphicx}

% TikZ
\usepackage{tikz}
%\usetikzlibrary{arrows.meta, decorations.pathmorphing, decorations.pathreplacing, shapes.geometric,mindmap}
%\usetikzlibrary{shapes.geometric,fadings,bayesnet}

% beamer styles
\mode<presentation>{
\usetheme{Warsaw}
%\usetheme{Antibes}
\usecolortheme{beaver}
%\usecolortheme{seahorse}
%\usefonttheme{structureitalicserif}
\setbeamercovered{transparent}
}
\setbeamertemplate{blocks}[rounded][shadow=true]
\AtBeginSubsection[]{
  \begin{frame}<beamer>{Contents}
    \tableofcontents[currentsection,currentsubsection]
  \end{frame}
}
%\useoutertheme[]{tree}

% title, etc
%\title{Network based drug repurposing for Alzheimer's disease}
\title{A multi-OMIC network based approach to drug repurposing for Alzheimer's}
\subtitle{A subtitle may be shorter and more technical}
\author{poster \#96}
\date{}

\begin{document}

\begin{frame}{Network based drug repurposing for Alzheimer's disease}
	{\emph{Attila Jones, Andrew Williamson, Vijay Varma, Jackson Roberts, Madhav Thambisetty}\\
		Clinical \& Translational Neuroscience Section, Laboratory of Behavioral Neuroscience}
	{\Large Alzheimer's disease (AD) gene sets:}
\begin{enumerate}
\item experimentally established AD genes from \alert{knowledge} bases
\item statistical evidence from \alert{TWAS}, transcriptome-wide association studies
\item an \alert{incipient proteo}mic AD signature (next talk)
\end{enumerate}
%\begin{description}
%\item[Knowledge] experimentally established role in AD
%\item[TWAS] statistical evidence from 4 omic studies
%\item[Incipient proteo.] incipient AD proteomic signature (next talk)
%\end{description}

\begin{center}
\includegraphics[scale=0.6]{../../../notebooks/2021-07-01-high-conf-ADgenes/named-figure/knowledge-twas-proteo-venn.pdf}
\end{center}
\begin{columns}[t]
\begin{column}{0.5\textwidth}
\end{column}

\begin{column}{0.5\textwidth}

\end{column}
\end{columns}
\end{frame}

\begin{frame}{Network based drug repurposing for Alzheimer's disease}
	{\emph{Attila Jones, Andrew Williamson, Vijay Varma, Jackson Roberts, Madhav Thambisetty}\\
		Clinical \& Translational Neuroscience Section, Laboratory of Behavioral Neuroscience}
\begin{columns}[t]
\begin{column}{0.4\textwidth}
{\small Cheng et al 2018 Nat Commun}

\includegraphics[width=1.0\columnwidth]{../figures/from-others/cheng-desai-2018-Nat-comm-Fig4a.png}
\end{column}

\begin{column}{0.6\textwidth}
\begin{itemize}
\item disease modules in the protein-protein
	interactome
\item targets proximal to disease module $\Rightarrow$ drug repurposing
%\item Hydroxychloroquine (next talk): proximal to CAD module
\item HCQ repurposing to CAD:
	validated by Cheng et al%pharmaco-epid.~\& \emph{in vitro} assay
\end{itemize}
\vfill

\begin{center}
{\Large Plan:}
\end{center}

\begin{enumerate}
\item apply to Alzheimer's
\item experimental validation
\begin{itemize}
	\item[DREAM] {\tiny Drug Repurposing for Effective Alzheimerâ€™s Medicine}
	\item[PREVENT-AD] {\tiny Preclinical Validation of Emerging Novel Treatments for Alzheimer's Disease}
\end{itemize}
\end{enumerate}
\end{column}
\end{columns}
\end{frame}

\end{document}


\begin{columns}[t]
\begin{column}{0.5\textwidth}

\end{column}

\begin{column}{0.5\textwidth}

\end{column}
\end{columns}
